Clinical Trials Logo

Dementia Alzheimers clinical trials

View clinical trials related to Dementia Alzheimers.

Filter by:

NCT ID: NCT05260515 Not yet recruiting - Clinical trials for Mild Cognitive Impairment

Protecting Alzheimer Caregivers Using Technology Through Staying Sharp

PROACTS
Start date: April 30, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

PROACTS is a Phase I/II study to assess the efficacy of AARP Staying Sharp online health program, focusing on the health of non-professional home-based caregivers of persons with Alzheimer's disease and related dementias (ADRD). PROACTS has three aims. Aim 1&2 is an one-time survey study to evaluate the current uptake and utilization of Staying Sharp among caregivers. Aim 3 is a single-group intervention to assess how Staying Sharp may maintain health and function for caregivers of persons with ADRD. Participants will participate in a 4-month program with a 4-month follow-up. Aim 1&2: Characterize caregivers of persons with ADRD using Staying Sharp and evaluate user experiences of Staying Sharp. Aim 3: Establish preliminary efficacy of Staying Sharp program.

NCT ID: NCT05245903 Not yet recruiting - Alzheimer Disease Clinical Trials

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

Emerald-NRAD
Start date: May 2022
Phase:
Study type: Observational

This project's main goal is to use state-of-the-art passive sensing techniques to identify digital biomarkers that relate to bioenergetic changes in the brain due to nicotinamide riboside supplementation in those with mild cognitive impairment and mild Alzheimer's dementia.

NCT ID: NCT05187819 Recruiting - Dementia Alzheimers Clinical Trials

Blood-based Biomarkers for Diagnosis of Alzheimer's

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

Alzheimer's disease (AD) may currently be diagnosed using molecular biomarkers in cerebrospinal fluid (CSF) and/or positron emission tomography (PET). These diagnostic procedures are highly accurate, but the high cost and low availability hamper their feasibility. Recently, ultrasensitive blood tests predicting Alzheimer pathologies in the brain have been developed. These tests have a reliable ability to differentiate AD from other neurodegenerative disorders and identify AD across the clinical continuum with high sensitivity and specificity in research cohorts with a high prevalence of AD. This project will assess the predictive value of these tests in a general practice population. The hypothesis is that the actual blood panel will have high positive predictive value for a diagnosis of Alzheimer's disease in the primary health care setting.

NCT ID: NCT05165186 Recruiting - Dementia Clinical Trials

Care Planning for a Loved One With Dementia: Knowledge, Preparing for Decisions, and Emotions

Start date: April 13, 2022
Phase: N/A
Study type: Interventional

The overall objective of this study is to compare knowledge, decisional conflict, preferences, and caregiver burden over time caregivers of Alzheimer's Disease and Related Dementias (ADRD) patients by comparing the effectiveness of a video decision aid intervention and enhanced usual care.

NCT ID: NCT05023564 Recruiting - Dementia Clinical Trials

PUMCH Dementia Longitudinal Cohort Study

Start date: December 1, 2020
Phase:
Study type: Observational

The PUMCH Dementia Cohort is a hospital-based, observational study of Chinese elderly with cognitive impairment.

NCT ID: NCT04948866 Enrolling by invitation - Alzheimer Disease Clinical Trials

Palliative Care for Persons With Late-stage Alzheimer's and Related Dementias and Their Caregivers

ADRD-PC
Start date: July 26, 2021
Phase: N/A
Study type: Interventional

Millions of Americans have late-stage Alzheimer's and related dementias (ADRD), causing suffering due to loss of awareness of self and family, progressive dependency, physical and neuropsychiatric symptoms, and physical, emotional and financial strain for caregivers. Investigators now propose a multi-site randomized clinical trial of the ADRD Palliative Care (ADRD-PC) program for persons with late-stage ADRD and their family caregivers, triggered during hospitalization. Investigators aim to learn if this program of dementia-specific palliative care, standardized caregiver education, and transitional care is effective to reduce burdensome hospital transfers, improve symptom treatment and control, augment supportive services, and reduce nursing home transitions for patients, and to improve caregiver outcomes of communication, shared decision-making and distress.

NCT ID: NCT04924361 Recruiting - Dementia Clinical Trials

Exploring Biomarkers in Age Stratified PUMCH Dementia Cohort

Start date: December 1, 2020
Phase:
Study type: Observational

Biomarkers are important for early and precise diagnosis of dementia. However, the causes of dementia in different age are different. We designed an age stratified dementia cohort and tried to explore biomarkers of different groups of dementia, incorporating neuropsychology, multi-model neuroimaging, metabolics and proteomics based fluid biomarkers as well as genetic biomarkers. Autopsy after clinical follow up help to verify the biomarkers.

NCT ID: NCT04871698 Recruiting - Dementia Clinical Trials

On Site Sensors Monitoring Impacts of Cognitive Decline on ADLs

Start date: September 14, 2020
Phase:
Study type: Observational [Patient Registry]

The purpose of this research is to compare the effectiveness of a continuous monitoring system to assess Activities of Daily Living (ADLs) over time compared to the traditional assessments used by medical professionals as Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) progresses.

NCT ID: NCT04863859 Recruiting - Dementia Clinical Trials

Persons With Dementia and Their Extended Family Caregivers

CareEx
Start date: September 11, 2021
Phase:
Study type: Observational

Immediate family members shoulder the majority of care responsibilities for persons living with dementia. However, due to various societal changes, elder care responsibilities have expanded to extended family members, including grandchildren, siblings, nieces/nephews, siblings, and step-kin. The main objective of this study is to understand the caregiving journeys of various extended family members involved in dementia care. We aim to learn about caregivers' care management strategies; their use of home and community-based services and informal support; and barriers to service usage. We will use the results from the study to help enhance service delivery, alleviate care-related stress, and improve the quality of life of dementia patients and their caregivers. We will use a mixed-methods design to explore the challenges faced by caregivers as well as their service usage for the person living with dementia. Our methodology involves an initial telephone interview (approx. 70 minutes) that includes open-ended questions, standard items, and structured measures, followed by an 8-day semi-structured daily diary interview about daily care responsibilities and experiences with services (15-20 minutes each evening). This study will be conducted with 240 extended family members serving as one of the main caregivers for a person living with dementia in a community setting.

NCT ID: NCT04851691 Enrolling by invitation - Alzheimer Disease Clinical Trials

An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions

Start date: August 3, 2021
Phase: N/A
Study type: Interventional

The goal of this study will be to design, implement and test the impact of a quality improvement (QI) intervention that uses an EHR CDS tool among physicians newly ordering an antipsychotic medication for older adults with ADRD. The study team hypothesizes that the intervention will reduce each participating clinician's pill days per patient prescribed.